Scott B. Capps, VP-Clinical Research at CRYOLIFE INC (CRY), sold 25,000 shares at $10.60 ($265K) on 2013-11-27, disclosed to the SEC on 2013-12-02.
Open-market sale of $265k CRY by VP-Clinical Research. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| CRY | SELL | 2019-06-03 | $57K | — | Filing → |
| CRY | SELL | 2018-09-04 | $432K | — | Filing → |
| CRY | SELL | 2017-02-24 | $364K | — | Filing → |